Medical Digest & Congress Report

Episódios

• 
  ACASA-TAVI: Antithrombotic Therapy After TAVI - report from ESC 2026 10.09.2026 5min

  Prof. Oyvind H. Lie presents trial findings on antithrombotic management following transcatheter aortic valve implantation (TAVI) at the ESC Congress 2026, evaluating optimal regimen strategies to balance ischemic risk reduction and bleeding complications.Video: https://medicaldigest.org/scientific-contents/interview:acasa-tavi-antithrombotic-therapy-after-tavi
• 
  REACT: Prevalence of Silent Atherosclerosis Across Adult Life - report from ESC 2026 10.09.2026 6min

  Prof. Henning Bundgaard presents landmark data from the REACT study at the ESC Congress 2026, mapping the prevalence of silent atherosclerosis across early to late adulthood and highlighting the role of early vascular imaging in primary prevention.Video: https://medicaldigest.org/scientific-contents/interview:react-prevalence-silent-atherosclerosis-across-adult-life
• 
  LDL Cholesterol Management in CAD: From ARMYDA to AMUNDSEN - report from ESC 2026 10.09.2026 10min

  Prof. Giuseppe Patti tracks the evolution of low-density lipoprotein cholesterol management in coronary artery disease at the ESC Congress 2026, drawing insights from the ARMYDA trials to the landmark AMUNDSEN study to optimize lipid-lowering strategies.Video: https://medicaldigest.org/scientific-contents/interview:ldl-cholesterol-management-cad-armyda-amundsen
• 
  Comorbidities Require Special Attention in Atrial Fibrillation - report from ESC 2026 10.09.2026 7min

  Prof. Ratika Parkash explores the critical role of managing comorbid conditions in atrial fibrillation at the ESC Congress 2026, emphasizing tailored risk factor modification and comprehensive multidisciplinary care.Video: https://medicaldigest.org/scientific-contents/interview:comorbidities-require-special-attention-atrial-fibrillation
• 
  How to Personalise the Treatment of Atrial Fibrillation - report from ESC 2026 10.09.2026 6min

  Prof. Helmut Puererfellner explores tailored approaches to atrial fibrillation management at the ESC Congress 2026, focusing on patient-specific symptom burdens, ablation vs. medical therapy, and targeted risk factor modification.Video: https://medicaldigest.org/scientific-contents/interview:how-personalise-treatment-atrial-fibrillation
• 
  2026 ESC Guidelines for the Management of Cardiovascular Disease and Chronic Kidney Disease 10.09.2026 5min

  Prof. Kevin Damman outlines the new 2026 ESC Guidelines for managing cardiorenal syndrome at the ESC Congress 2026, focusing on early intervention, risk stratification, and integrated treatment approaches for co-existing CVD and CKD.Video: https://medicaldigest.org/scientific-contents/interview:2026-esc-guidelines-management-cardiovascular-disease-and-chronic-kidney-disease
• 
  Practical Implementation of the ESC Atrial Fibrillation Guideline - report from ESC 2026 10.09.2026 9min

  Prof. Michiel Rienstra discusses the practical implementation of the ESC Atrial Fibrillation Guidelines at the ESC Congress 2026, offering actionable strategies to streamline clinical workflows and optimize patient care.Video: https://medicaldigest.org/scientific-contents/interview:practical-implementation-esc-atrial-fibrillation-guideline
• 
  2026 ESC Guidelines for the Management of Heart Failure - report from ESC 2026 10.09.2026 6min

  Prof. Marianna Adamo outlines the updated 2026 ESC Guidelines for the Management of Heart Failure at the ESC Congress 2026, highlighting essential advances in diagnosis, early therapy initiation, and disease management.Video: https://medicaldigest.org/scientific-contents/interview:2026-esc-guidelines-management-heart-failure
• 
  SWITCH SWEDEHEART: Switching Ticagrelor to Prasugrel in ACS - report from ESC 2026 10.09.2026 10min

  Prof. Elmir Omerovic presents key results from the SWITCH SWEDEHEART trial at the ESC Congress 2026, evaluating the safety and efficacy of switching from ticagrelor to prasugrel in patients with acute coronary syndromes.Video: https://medicaldigest.org/scientific-contents/interview:switch-swedeheart-switching-ticagrelor-prasugrel-acs
• 
  From Guidelines to Clinical Impact: Key Takeaways on GDMT Implementation – Report from ESC 2026 10.09.2026 7min

  Prof. Piotr Ponikowski discusses the critical gap between heart failure guidelines and real-world clinical practice, exploring the missing pieces needed for successful guideline-directed medical therapy (GDMT) implementation.Video: https://medicaldigest.org/scientific-contents/interview:guidelines-clinical-impact-key-takeaways-gdmt-implementation-report-esc-2026
• 
  Start Early, Start in Hospital: Translating Heart Failure Guidelines into Practice - report from ESC 2026 10.09.2026 6min

  Prof. Shelley Zieroth addresses the critical importance of early, in-hospital initiation of guideline-directed medical therapy for heart failure at the ESC Congress 2026, highlighting practical strategies to improve patient outcomes during post-discharge transition.Video: https://medicaldigest.org/scientific-contents/interview:start-early-start-hospital-translating-heart-failure-guidelines-practice
• 
  Main Highlights and Key Clinical Takeaways of ESC 2026 10.09.2026 5min

  Prof. Felix Mahfoud summarizes the main highlights and key clinical takeaways from the ESC Congress 2026, showcasing practice-changing trial results, new guidelines, and breakthroughs across AI, cardiometabolic disease, and interventional cardiology.Video: https://medicaldigest.org/scientific-contents/interview:main-highlights-and-key-clinical-takeaways-esc-2026
• 
  From Guidelines to Clinical Impact: GDMT Implementation - report from ESC 2026 10.09.2026 6min

  Prof. Giuseppe Rosano addresses key challenges in implementing guideline-directed medical therapy at the ESC Congress 2026, exploring strategies to bridge the gap between clinical recommendations and real-world cardiovascular care.Video: https://medicaldigest.org/scientific-contents/interview:guidelines-clinical-impact-gdmt-implementation
• 
  SINGLE-AF: Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk - report from ESC 2026 10.09.2026 5min

  Prof. Boyoung Joung presents findings from the landmark SINGLE-AF trial at the ESC Congress 2026. The study demonstrates that direct oral anticoagulants (DOACs) significantly reduce stroke risk in atrial fibrillation patients at intermediate risk without increasing major bleeding.Video: https://medicaldigest.org/scientific-contents/interview:single-af-anticoagulation-atrial-fibrillation-intermediate-stroke-risk
• 
  ENRICH-AF: Edoxaban in Intracranial Hemorrhage Survivors with Atrial Fibrillation - report from ESC 2026 10.09.2026 5min

  Prof. Ashkan Shoamanesh presents key findings from the ENRICH-AF trial at the ESC Congress 2026. The study evaluates whether edoxaban safely reduces stroke risk in high-risk atrial fibrillation patients with a history of intracranial hemorrhage, highlighting crucial trade-offs between ischemic stroke prevention and major bleeding risks. Video: https://medicaldigest.org/scientific-contents/interview:enrich-af-edoxaban-intracranial-hemorrhage-survivors-atrial-fibrillation
• 
  5th Universal Definition of Myocardial Infarction - report from ESC 2026 10.09.2026 7min

  Prof. Kristin Newby breaks down the new 5th Universal Definition of Myocardial Infarction at the ESC Congress 2026, highlighting refined diagnostic criteria and global clinical consensus.Video: https://medicaldigest.org/scientific-contents/interview:5th-universal-definition-myocardial-infarction
• 
  2026 ESC Guidelines on Cardiac Rehabilitation 10.09.2026 7min

  Prof. Matthias Wilhelm outlines the updated 2026 ESC Guidelines on Cardiac Rehabilitation at the ESC Congress 2026, focusing on personalized training and modern secondary prevention strategies.Video: https://medicaldigest.org/scientific-contents/interview:2026-esc-guidelines-cardiac-rehabilitation
• 
  Control the modifiable risk factors to prevent dementia: Insights from the 10/66 studies 28.07.2026 8min

  Professor Daisy Acosta delivers an essential expert overview on the shifting landscape of dementia prevalence across Latin America, building on crucial insights from the 10/66 studies. This concise brief highlights the unexpected increase in dementia prevalence over the past two decades across multiple catchment sites, contrasting sharply with the declining trends observed in high-income countries. Professor Acosta underscores the growing and uneven burden facing the region, outlining a critical roadmap that emphasizes the urgent need for strengthened surveillance, targeted risk reduction strategies, and substantial infrastructure investment to control modifiable risk factors and prevent dementia before it overwhelms healthcare systems.Video: https://medicaldigest.org/scientific-contents/interview:control-modifiable-risk-factors-prevent-dementia-insights-1066-studies
• 
  The New Landscape of Alzheimer’s Therapy: Targets, Treatments, and Future Outlook 22.07.2026 13min

  Professor Takaomi C. Saido, world renowned scientist, delivers a comprehensive expert overview on the current state of Alzheimer's disease research, moving past traditional models to explore groundbreaking therapeutic targets. This concise brief highlights the mechanisms behind approved disease-modifying therapies, the crucial role of neprilysin and somatostatin receptor in amyloid clearance, and the development of next-generation knock-in mouse models mapping the complex amyloid-tau pathology pathways. Professor Saido outlines a visionary roadmap toward preventing Alzheimer's before the clinical onset of cognitive impairment.Video: https://medicaldigest.org/scientific-contents/interview:new-landscape-alzheimers-therapy-targets-treatments-and-future-outlook
• 
  Highlights of ISTH Guidelines and Guidance Documents - report from ISTH 2026 21.07.2026 6min

  Dr. James Douketis delivers an essential overview of the key highlights from the newly updated ISTH guidelines and guidance documents at the ISTH 2026 Congress. This targeted brief focuses on practical, evidence-based clinical recommendations, highlighting two major clinical updates:Surgical and Procedural Bleed Risk Stratification for Anticoagulated Patients Undergoing Planned Surgery – A refined, three-tier classification framework to optimize periprocedural anticoagulation management.Monitoring and Management of Therapeutic-dose UFH in Practice – Key updates on standardizing and improving the safety of therapeutic unfractionated heparin (UFH) dosing and monitoring.Video: https://medicaldigest.org/scientific-contents/interview:highlights-isth-guidelines-and-guidance-documents